Encore: Diet Wars | Losing Streak | 4

Encore: Diet Wars | Losing Streak | 4

Up next

Encore: Diet Wars | Dieting 3.0 | 5

First there was Weight Watchers, then there was Noom, and now there’s…Wegovy? Bloomberg health reporter Emma Court helps us understand the evolution of dieting programs and where they’re going next. Later, Matthew Schnier of New York Magazine and The Cut walks us through his arti ...  Show more

Best of Business Wars Daily | Chat Chat Revolution | 6

The AI revolution is here and the tech behemoths are building and releasing their own chatbots. To talk about their victories and blunders, we're joined by Vox journalist Shirin Ghaffary and comedian and podcast host Jolenta Greenberg.Binge all episodes early and ad-free with Won ...  Show more

Recommended Episodes

Can WeightWatchers survive the Wegovy era?
The Story of Money

WeightWatchers is struggling. Launched in the early 1960s, the brand grew by helping members shed pounds through behavioural change programmes. Then, GLP-1 anti-obesity drugs hit the market, long-time spokesperson and board member Oprah Winfrey announced her departure, and the ...

  Show more

WeightWatchers CEO Explains Why ‘We Got It Wrong’
Chasing Life with Dr. Sanjay Gupta

Long before WeightWatchers became a weight loss empire, the legacy dieting company started as a small support group in the 1960s. The company rose to popularity preaching a message of moderation and making healthy choices. But in what some call a surprising pivot, WeightWatchers ...  Show more

Gyms in the Era of Ozempic
Business Wars Daily

Today is Thursday, March 14, and we're looking at Life Time vs. Xponential Fitness.Listen to Business Wars Daily on the Wondery App or wherever you get your podcasts. You can listen to all episodes ad-free on Wondery+. Join Wondery+ in the Wondery App, Apple Podcasts or Spotify. ...  Show more

Deep Dive: How Junk Food Giants Are Battling GLP-1s & RFK Jr.’s Health Crusade
The Rundown

The junk food industry is facing a major shake-up as consumer habits shift, weight-loss drugs like Ozempic gain traction, and government intervention ramps up. From declining snack sales at PepsiCo and Mondelez to Robert F. Kennedy Jr.’s crackdown on artificial additives and j ...

  Show more